"The immuno-oncology drug development pipeline: the next wave" is a commercial report detailing 60+ targets and the corresponding drug candidates and their development status and references over 150 companies. First published May 2018 (and continually updated). A sample report may be viewed and downloaded here Downloadable content.
Archived blogarticles (before January 2013) are available from the downloadable content page
"Business Development Basics. A Guide for Early-Stage Life Science Companies" can be found here:Downloadable content. Feedback, comments and suggestions for an expanded 2nd Edition are welcomed.